热点
"功效声明" 相关文章
FDA’s OPDP Issues Second Regulatory Action Letter of 2023
Eye on FDA 2025-09-29T02:49:20.000000Z
FDA’s OPDP Issues Two New Untitled Letters
Eye on FDA 2025-09-29T02:49:20.000000Z